上海醫藥(601607.SH)：I031獲得臨牀試驗批准通知書

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

上海醫藥(601607.SH)：I031獲得臨牀試驗批准通知書

格隆匯 05-13 18:01

格隆匯5月13日丨上海醫藥(601607.SH)公佈，公司自主研發的“I031片”收到國家藥品監督管理局核准簽發的《藥物臨牀試驗批准通知書》，I031是一款小分子抑制劑，能對腫瘤增殖產生抑制作用。臨牀前研究顯示I031能在人源腫瘤動物模型上起到抑制腫瘤生長的作用。該項目由上海醫藥自主研發，公司擁有完全知識產權。

上海醫藥(02607.HK)

Relevant Stocks

上海醫藥(02607.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

上海醫藥(601607.SH)：I031獲得臨牀試驗批准通知書

Services

About Us

Agreement Statement